通过双特异性抗体成功向多抗药性瘤
Raffaella Briante1, Qianting Zhai2, Suchismita Mohanty3
1Antibody Engineering, Kenjockety Biotechnology Inc, Tiburon, CA, USA.
mAbs
|April 18, 2025
概括
新的双特异性抗体 (BsAbs) 针对多耐药 (MDR) 癌细胞的P-glycoprotein (P-gp) 和CD47,恢复化疗敏感性,并提供强大的抗瘤效应,降低毒性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症化疗中的多药性耐药性 (MDR) 通常是由P-glycoprotein (P-gp) 排泄过度表达引起的.
- 以前使用小分子P-gp对抗剂的尝试由于对正常组织的不良影响而失败.
研究的目的:
- 开发一种新的双特异性抗体 (BsAb) 方法来克服P-gp介导的MDR.
- 将P-gp和CD47同时向MDR癌细胞,以提高疗效和降低毒性.
主要方法:
- 针对P-gp和CD47.7的双特异抗体 (BsAbs) 的设计和表征.
- 在临床前MDR异种移植瘤模型中评估BsAb的疗效.
- 评估BsAbs作为单独的药物和与帕克利塔塞尔联合使用.
主要成果:
- 在三种不同的MDR异种移植模型中,BsAbs有效地恢复了瘤对帕克利塔塞尔的敏感性.
- 观察到BsAbs具有显著的抗瘤疗效,无论是单独使用还是与帕克利塔塞尔一起使用.
- BsAb方法证明了瘤特异性向,对正常组织的毒性降低.
结论:
- 针对P-gp和CD47的双特异性抗体提供了一种有希望的策略来对抗MDR癌症.
- 这种新的方法提供了多式模式的作用机制,瘤特定的向和广泛的适用性.
- 与小分子抗剂相比,BsAbs是一种进步,具有降低全身毒性的潜力.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


